Valerio Therapeutics Financial Overview
Valerio Therapeutics's market cap is currently €71.30M. The company's EPS TTM is €; its P/E ratio is -1.67; Valerio Therapeutics is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
